- Details
- Written by IVN
- Category: Health News
San Diego, California - Deputy Surgeon General Rear Admiral Sylvia Trent-Adams will visit the San Diego State University campus tomorrow to discuss the health and well-being of the American public.
- Details
- Written by IVN
- Category: Health News
Washington, DC - The U.S. Food and Drug Administration today cleared the first duodenoscope with a disposable distal cap, a new feature that will improve access for cleaning and reprocessing. The Pentax ED34-i10T model duodenoscope is intended to provide visualization and access to the upper gastrointestinal (GI) tract to treat bile duct disorders and other upper GI problems.
- Details
- Written by Evelyn A Brown - NIST
- Category: Health News
Washington, DC - Cardiovascular disease caused one out of three deaths (link is external) in the United States in 2016, and for decades it has been the leading killer for both men and women. Hoping to reduce these numbers, researchers at the National Institute of Standards and Technology (NIST) have developed a new Standard Reference Material (SRM) that can improve the results of a common blood test used to assess a person’s risk of heart disease.
- Details
- Written by Deborah Kotz
- Category: Health News
Washington, DC - FDA Commissioner Scott Gottlieb, M.D.: "As the science governing allergies and diets continues to evolve, so do expert recommendations around how best to safely introduce babies and children to various foods. Perhaps one of the most challenging decisions for parents of my generation is when and how to introduce foods that pose a potential for a significant allergic reaction. These decisions are made more difficult as the prevalence of certain food allergies appear to be on the rise.
- Details
- Written by KXO Radio
- Category: Health News
El Centro, California - The County Public Health Department is investigating a suspected case of Hepatitis A case reported recently in Imperial County.
- Details
- Written by IVN
- Category: Health News
Washington, DC - The U.S. Food and Drug Administration today approved Mylotarg (gemtuzumab ozogamicin) for the treatment of adults with newly diagnosed acute myeloid leukemia whose tumors express the CD33 antigen (CD33-positive AML). The FDA also approved Mylotarg for the treatment of patients aged 2 years and older with CD33-positive AML who have experienced a relapse or who have not responded to initial treatment (refractory).
Page 66 of 374
